Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene Citrate for Opioid-Induced Androgen Deficiency
NCT01880086Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Aug 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clomiphene in opioid-induced androgen deficiency (OPIAD), sponsored by Weill Cornell Medicine. Started Aug 2013; status: completed.
02
Drugs
clomiphene
03
Conditions
opioid-induced androgen deficiency (OPIAD)
Beyond the preview
Go deeper on NCT01880086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880086.